Use of oxymetazoline in the management of epistaxis.
The purpose of this study was to determine if use of an intranasal vasoconstrictor (oxymetazoline) could be used to effectively treat epistaxis, avoiding nasal packing. The charts of 60 patients who presented to the emergency room with the diagnosis of epistaxis and who required medical management were reviewed. Sixty-five percent of these patients were successfully managed with oxymetazoline as their sole therapy. An additional 18% were managed successfully with silver nitrate cautery in combination with oxymetazoline. In only 17% of patients was it necessary to use nasal packing as treatment for epistaxis after an initial attempt with oxymetazoline alone or in combination with silver nitrate failed. These data suggest that pharmacologic management may be adequate in the majority of patients with epistaxis, thus avoiding the need for nasal packing with its associated complications.
Krempl
G A
GA
Department of Otolaryngology-Head and Neck Surgery, University of Texas Health Science Center at San Antonio, USA.
Noorily
A D
AD
D000328:Adult; D002425:Cautery; D004334:Drug Administration Schedule; D004844:Epistaxis / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010109:Oxymetazoline / Q000008:administration & dosage / Q000627:therapeutic use*
D010109:Oxymetazoline